Nanosilicone Particles For Breast Implants and Other Silicone Based Devices


Florida International University (FIU) is pursuing a commercial partner interested in developing Novel Silicone Nanoparticles. Investigators at FIU designed and tested novel silicone nanoparticles that can provide a significant advantage compared to silicone microparticles. The silicone nanoparticles can be engineered to elude the body’s immune recognition and avoid subsequent silicone related toxicity and adverse effects.

  • Breast Implants
  • Reconstructive Mammoplasty
  • Cosmetic and Plastic Surgery
  • Bypasses the immune system and causes less inflammation and adverse immune responses.
  • Provides a safer alternative for silicone use in patients and in devices.

Silicone nanoparticles do not induce immune responses by na’ve human peripheral blood mononuclear cells: implications in breast implants.

Plast Reconstr Surg. 2012 Jul;130(1):128e-137e.

Nair N, Pilakka-Kanthikeel S, Saiyed Z, Yndart A, Nair M.


For additional information about this technology opportunity, please contact Elizabeth Garami at or by phone at 305-348-0008 and ask about record IP 1204.